Knight Therapeutics Inc. (KHTRF)
OTCMKTS
· Delayed Price · Currency is USD
4.460
0.00 (0.00%)
May 8, 2025, 4:00 PM EDT
Knight Therapeutics Employees
Knight Therapeutics had 745 employees as of December 31, 2024. The number of employees increased by 20 or 2.76% compared to the previous year.
Employees
745
Change (1Y)
20
Growth (1Y)
2.76%
Revenue / Employee
$348,120
Profits / Employee
$10,331
Market Cap
406.72M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 3,116 |
Tian'an Technology Group | 8 |
Glass House Brands | 374 |
CytoDyn | 9 |
Elite Pharmaceuticals | 64 |
Northwest Biotherapeutics | 25 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
Knight Therapeutics News
- 1 day ago - Knight Therapeutics reports Q1 results - Seeking Alpha
- 1 day ago - Knight Therapeutics Reports First Quarter 2025 Results - GlobeNewsWire
- 2 days ago - Knight Therapeutics Inc. announces voting results from the Annual General Meeting - GlobeNewsWire
- 2 days ago - Knight Therapeutics Announces Relaunch of ONICIT® in Brazil and Mexico - GlobeNewsWire
- 8 days ago - Notice of Knight Therapeutics’ First Quarter 2025 Results Conference Call - Financial Post
- 8 days ago - Notice of Knight Therapeutics' First Quarter 2025 Results Conference Call - GlobeNewsWire
- 6 weeks ago - Knight Therapeutics Announces Launch of Minjuvi® (tafasitamab) in Mexico - Benzinga
- 7 weeks ago - Knight Therapeutics Inc. (KHTRF) Q4 2024 Earnings Call Transcript - Seeking Alpha